Mobile Clinics Bring Care Closer in Comoros: How UNFPA-supported services are transforming the lives of women in the islands
At 26, Sitty was expecting for the third time. On her first visit to the mobile clinic, she was exhausted but curious. Alongside other women from her village, she entered a large tent pitched under the shade of the trees. Inside, she says she discovered much more than care. She discovered a space for listening, respect, and learning. She found another world. Women in scrubs spoke to her gently, patiently explaining things.
'I learned things I didn't know before,' she says. 'Like how you can prepare for breastfeeding during pregnancy, or the right way to position your baby when feeding.'
For Sitty, this was transformative. The clinic also introduced her to family planning, an unspoken subject in her community. For the first time, she understood that birth spacing was not only possible, but her right. It was a way to protect her health, regain her strength between pregnancies, and give her children the attention they deserved.
Breaking the distance barrier
The mobile clinic on the island of Anjouan has been in use since 2020. Funded by UNFPA, the space is a much-needed safe haven for pregnant women. From the Village of Bougweni, the nearest hospital, Sima Health Center, is 10 kilometers away, a hard distance for a pregnant woman to reach on foot.
"Sometimes, after a late period, you think you might be pregnant, but the journey, especially when you have to travel miles, makes you less likely to want to go to the doctor. Sometimes you don't even have enough taxi fares. Then you get to a point where you think you're just waiting for the birth,' explains Hanati Sidi, 37. Hanati is expecting her fourth child and shares the relief and happiness of having a clinic that's close.
Consistency is key
The regular arrival of the mobile clinic, with the support of UNFPA, breaks this isolation. With UNFPA's innovation and deployment of the mobile clinic, the rhythm of life for women in Bougweni has changed. Because the Mobile Clinic not only treats but also directs and encourages pregnant women to go to the hospital to prevent preventable maternal deaths.
'I wish she would come more often. I won't hide it from you, when she comes here to Bougweni, everyone is happy. It's like when it's the dry season and you see the rain fall. Currently, I'm waiting for the clinic to check my vaccinations and be up to date,' Sitty explains.
The clinic provides essential healthcare services, including medication, personalized advice, and a compassionate ear. It embodies a humanistic approach, reaching out to those isolated by distance and lack of resources, assuring them they are not alone.
As a result, women like Sitty and Hanati are better informed and more empowered. While the mobile clinic is only a part of our interventions and actions, it paves the way for prevention, fosters autonomy, and restores dignity.
Distributed by APO Group on behalf of UNFPA - East and Southern Africa.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Zawya
12 hours ago
- Zawya
Saudi: Fakeeh group delivers H1 2025 revenue of $402.4mln, up 13% year-on-year
Dr Soliman Abdel Kader Fakeeh Hospital Company and its Subsidiaries ('Fakeeh Care Group', 'FCG', 'Fakeeh Care', the 'Company' or the 'Group'), a leading fully integrated academic healthcare provider listed on TASI (SYMBOL: 4017 and ISIN code SA562GSHUOH7), announced its financial results[1] for the second quarter ended 30 June 2025. Growth during the quarter was supported by higher patient volumes and a richer case‑mix as activity normalized post‑Ramadan. The total number of patients served reached 465 thousand+ in 2Q‑2025 (+16% YoY), taking 1H‑2025 volumes to ~900 thousand (+8% YoY). Outpatient and inpatient volumes grew 15% and 16%, respectively, in the quarter translating into combined revenue growth of 18%. Pricing and case‑mix tailwinds added support to the average revenue per outpatient visit and inpatient admission contributing 3% YTD on a consolidated revenue level. Jeddah's double‑digit growth was central driver, complemented by accelerating throughput in Riyadh and early activity in Madinah. At the headline level, the Group delivered 2Q‑2025 revenue of SR812 million (+24% YoY) and Net Profit after Zakat of SR68 million (+59% YoY); 1H‑2025 revenue was SR1.51 billion (+13% YoY). Commenting on the Group's performance, FCG's President Dr. Mazen Soliman Fakeeh said: 'In the second quarter of the year, Fakeeh Care Group revenues reached to SR812 million, posting a solid 24% year on year growth thanks to a 16% year‑on‑year growth of patients served and a richer case mix. Jeddah's year-on-year expansion in census and revenue continues to demonstrate the strength of our brand and clinical depth, while Riyadh's disciplined ramp‑up continues to progress—together with the recently opened DSFH Madinah—our geographic reach continues to broaden. Our platform remained a robust earnings engine with Attributable to Shareholders profits reaching SR154 million in the first half (SR82M in 2Q25) or 28% up year-on-year, after absorbing the anticipated start‑up operating losses from ramping facilities —investments that are underpinning our multi‑year growth trajectory. In Riyadh, operational beds increased to 102 (from 71 a year earlier), supporting mid‑30% growth in outpatient and inpatient volumes and a sharp rise in surgical throughput as higher‑complexity services scale. In Madinah, the Group admitted its first patients in the initial 48 beds (of 200 beds) under a disciplined, quality‑first ramp that is expected to build steadily. In Jeddah, the flagship network remained the primary revenue center, sustaining double‑digit volume growth and strong pull‑through across service lines. The Group broke ground on DSFMC Al Zahraa in Jeddah—developed in partnership with Yasser Yousef Naghi Investment Company—a key spoke in the hub‑and‑spoke strategy. The center will bring comprehensive, high‑quality care closer to the community via one‑day surgical suites, a 24/7 emergency department, an integrated diagnostic hub, and key medical specializations. Dr. Mazen Soliman Fakeeh added: 'Our integrated ecosystem—with tertiary hospitals, medical centers, home healthcare, emergency medical services, medical education, technology and retail medical offerings that complete our service continuum—continues to differentiate Fakeeh Care. We continue to invest in our digital infrastructure, embedding tools that optimize patient journeys, enhance resource utilization, and reinforce our value-based care model, elevating patient reported outcomes.' 'Looking ahead, our priorities are clear: drive utilization across our ramping facilities with strategic case mix refinement in Jeddah and Riyadh; execute a disciplined, quality first ramp in Madinah; advance milestones across our growth agenda; and continue embedding digital and data driven workflows that unlock efficiency while elevating care standards. We aim to further broaden our preventative medicine and early intervention offerings, strengthening longitudinal patient engagement. Throughout, we remain disciplined in capital deployment—preserving a conservative balance sheet as we fund expansion and cement the foundation for a highly scalable and sustainably profitable healthcare ecosystem. With a resilient mature platform, a scalable operating model, and a deepening role in the Kingdom's healthcare transformation, we are well positioned to create enduring value for patients, staff, students, shareholders and the broader community.' he concluded. During the quarter, the Group achieved JCI Enterprise Accreditation, becoming the first private healthcare group in the Kingdom to earn system‑wide endorsement—validating governance, safety culture, standardized clinical pathways and enterprise risk systems, and ensuring the quality DNA of the flagship facilities scales consistently as the network grows. In parallel, Fakeeh Emergency Medical Services (MedE) supported the Kingdom's Hajj operations through the mobilization of ambulatory teams and ambulances and the CSR operation of Namira Hospital at peak demand, deepening the Group's partnership with national health authorities and reinforcing its role in serving broader societal needs. Fakeeh Care Group's complete 2Q-2025 Earnings Release with management's analysis of the Company's performance is available for download on © Copyright 2022 The Saudi Gazette. All Rights Reserved. Provided by SyndiGate Media Inc. (


Zawya
14 hours ago
- Zawya
M42 announces breakthrough results for its AI-powered tuberculosis screening
M42, a global health leader powered by technology, artificial intelligence (AI) and genomics, has unveiled landmark findings from a large-scale population study on AI-powered tuberculosis (TB) screening, published in the prestigious scientific journal npj Digital Medicine - Nature. Conducted in collaboration with Capital Health Screening Centre (CHSC) in Abu Dhabi, part of the M42 group, the study is among the largest real-world clinical validations of an AI-driven healthcare solution to date, analyzing over one million chest X-rays (CXRs) to evaluate the efficacy and scalability of AI in TB screening. The study assessed AI Radiology in Screening TB (AIRIS-TB), M42's cutting-edge AI model engineered to streamline routine tuberculosis screenings, allowing radiologists to focus on more complex or urgent cases. AIRIS-TB demonstrated exceptional performance, achieving an Area Under the Receiver Operating Characteristic Curve (AUROC) of 98.5% - a clear indicator of its high efficiency in triaging CXRs for TB. With an estimated 10.8 million people falling ill from TB and a total of 1.25 million people dying from it in 2023, according to the World Health Organisation (WHO), and recent reports of TB returning to being the world's leading cause of death from a single infectious agent, M42's AIRIS-TB demonstrates the potential of AI solutions delivering real-world impact. AIRIS-TB reported an unprecedented 0% false-negative rate for tuberculosis-specific cases across the full dataset – an achievement that reinforces its safety and reliability as a workflow automation tool. In practical application, the model has the potential to safely automate up to 80% of routine CXR assessments, directly alleviating radiologist workload pressures, minimising the risk of human error, and delivering significant cost efficiencies in high-throughput low-prevalence settings. Presently, CXR review remains labor-intensive and prone to oversight and error, potentially leading to missed or delayed diagnoses, with a prior study stating a 26.6% increase in missed findings when radiologists double their annotation speed, and a rise in errors after 9 hours into their shift. Importantly, AIRIS-TB delivered consistently strong performance across a wide range of demographic groups, including variations in gender, age, HIV status, income levels, and a diverse population covering six WHO regions, highlighting the model's robustness, fairness and generalisability across diverse global populations. These results underscore AIRIS-TB's potential to significantly enhance clinical workflows and drive earlier, more equitable screening of TB in high-volume programmes worldwide. Dimitris Moulavasilis, Group CEO of M42, said, "This landmark study marks a pivotal moment in the potential power of AI in the global fight against tuberculosis. Our AIRIS-TB model stands as a compelling testament to the unmatched accuracy, safety and scalability that AI can deliver, particularly in resource-limited settings where there is a shortage of radiologists and the need to tackle TB is greatest. In regions with a high prevalence of TB, we now have a scalable technological solution that can bridge the divide, expand radiologist capacity and help save lives. These results signal the transformative role AI can play in reshaping global public health and redefining how healthcare is diagnosed, delivered and experienced worldwide.' Dr. Laila Abdel Wareth, CEO of Capital Health Screening Centre, added, "The outcomes of this study reaffirm that AI models like AIRIS-TB can not only match – but safely surpass – human-level accuracy and efficiency in clinical practice. By automating high-volume, routine screenings with precision, we are equipping radiologists to concentrate on complex and high-risk cases, unlocking greater diagnostic capacity. This shift holds immense potential to elevate patient outcomes, streamline healthcare delivery and bolster public health infrastructure on a global scale." The study underwent rigorous peer review and ethical oversight by the Department of Health – Abu Dhabi, ensuring transparency, accountability, and the highest standards of clinical integrity. Its publication in a leading scientific journal reinforces M42's position as a global pioneer in AI-led health solutions and solidifies the UAE's growing prominence as a global, data-driven hub for cutting-edge medical innovation and technology. The full study is accessible through npj Digital Medicine.

Economy ME
17 hours ago
- Economy ME
WHX Dubai, WHX Labs to gather 270,000 leaders from 180 nations to tackle global healthcare challenges
Informa has unveiled the launch of the world's largest healthcare event, following the decision to host two flagship gatherings simultaneously in 2026. From February 9 to 13, 2026, WHX Dubai (formerly known as Arab Health) and WHX Labs Dubai (previously Medlab Middle East) will convene over 270,000 healthcare leaders from 180 nations and more than 4,800 exhibitors, transforming Dubai into a global healthcare hub and a catalyst for medical advancement. For decades, these events have positioned Dubai at the core of global healthcare conversations. Set to occur concurrently in 2026, under the auspices of the UAE Ministry of Health and Prevention, they will merge to create the world's largest healthcare event—a city-wide opportunity for deal-making, networking, and knowledge-sharing that addresses universal healthcare and laboratory challenges. WHX Dubai will take place from February 9 to 12 at the Dubai Exhibition Centre (DEC) in Expo City Dubai, marking a historic milestone as the event will be held outside the Dubai World Trade Centre (DWTC) for the first time in its 50-year history. Record-breaking business value The exhibition will draw an international audience and serve as a global platform for innovation, allowing exhibitors to present solutions across nine diverse product sectors, including medical devices, imaging and diagnostics, and healthcare infrastructure. The 50th edition of this event, which occurred earlier this year, generated a record-breaking $2.57 billion in business value, with each exhibitor experiencing an average impact of $2.14 million. WHX Dubai 2026 is poised to enhance global health with a forward-thinking program that includes seven CME-accredited conferences and over 250 speakers. This edition will introduce four new certified boot camps and three dedicated stages: the Future X Stage for pioneering ideas; the Frontiers Stage, showcasing the latest advancements in science, wellness, and life sciences; and the Visionary Stage, where global leaders will offer insightful perspectives on investment, leadership, artificial intelligence, and ESG. As it marks its 25th anniversary in 2026, WHX Labs Dubai will occur from February 10 to 13 at DWTC. Under the theme '25 Years of Laboratory Innovation: Uniting Communities for Better Health,' the event will highlight excellence in laboratories, diagnostics, and precision medicine. Last year, WHX Labs Dubai generated $621 million in business, serving as a platform that connected key buyers, government ministries, and decision-makers driving diagnostics-related innovation and investment in the Middle East. Accelerating global healthcare solutions WHX Labs Dubai will showcase the latest advancements from across the medical lab ecosystem through eight product pillars. Additionally, the 25th Annual Laboratory Management and Medicine Congress will feature eight CME-accredited scientific conference tracks with 250 global thought leaders and laboratory specialists. Attendees can engage in industry-defining discussions at the WHX Labs Roundtables and partake in two new clinician conferences: the Precision Health Global Forum and the Antimicrobial Resistance Leadership Global Summit. Solenne Singer, senior vice president at Informa Markets, stated: 'WHX Dubai and WHX Labs Dubai are both well-established events with a proven track record of advancing knowledge and trade at both regional and global levels. We are delighted to host them concurrently to form the world's largest healthcare event, which will transform Dubai into a hub for the global healthcare ecosystem for five enlightening days. 'Dubai's unique position will enable bold ideas and breakthroughs to cross borders rapidly, accelerating the spread of solutions from one market to another while reinforcing the UAE's status as an international center for healthcare transformation. By hosting the world's largest healthcare event, our attendees will make a significant contribution to future advances in medical excellence and innovation in the UAE and beyond.'